• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

作者信息

Cui Yuying, Yao Jinming, Qiu Xiaodong, Guo Congcong, Kong Degang, Dong Jianjun, Liao Lin

机构信息

First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Jinan, China.

Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational medicine, Shandong Institute of Nephrology, Jinan, China.

出版信息

Diabetes Ther. 2024 Nov;15(11):2443. doi: 10.1007/s13300-024-01632-4.

DOI:10.1007/s13300-024-01632-4
PMID:39283412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11467149/
Abstract
摘要

相似文献

1
Correction to: Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.对《替尔泊肽在亚洲和非亚洲2型糖尿病患者中的疗效和安全性比较：系统评价和荟萃分析》的更正
Diabetes Ther. 2024 Nov;15(11):2443. doi: 10.1007/s13300-024-01632-4.
2
Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.替尔泊肽在亚洲和非亚洲2型糖尿病患者中的疗效和安全性比较：一项系统评价和荟萃分析
Diabetes Ther. 2024 Apr;15(4):781-799. doi: 10.1007/s13300-024-01540-7. Epub 2024 Feb 24.
3
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials.替尔泊肽治疗2型糖尿病患者的疗效和安全性：一项随机II/III期试验的系统评价和荟萃分析
Pharmaceuticals (Basel). 2021 Sep 28;14(10):991. doi: 10.3390/ph14100991.
4
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.皮下注射替西帕肽与司美格鲁肽治疗 2 型糖尿病成人患者的疗效比较：一项随机对照试验的系统评价和网络荟萃分析。
Diabetologia. 2024 Jul;67(7):1206-1222. doi: 10.1007/s00125-024-06144-1. Epub 2024 Apr 13.
5
Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials.在 2 型糖尿病中，每周替西帕肽与每周胰岛素的疗效和安全性比较：一项随机临床试验的网络荟萃分析。
Diabetes Obes Metab. 2024 Sep;26(9):3801-3809. doi: 10.1111/dom.15725. Epub 2024 Jun 25.
6
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.替尔泊肽治疗超重或肥胖的疗效和安全性：系统评价和荟萃分析。
Int J Obes (Lond). 2023 Aug;47(8):677-685. doi: 10.1038/s41366-023-01321-5. Epub 2023 May 31.
7
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.使用双重 GIP/GLP-1 受体激动剂替西帕肽治疗 2 型糖尿病：系统评价和荟萃分析。
Diabetologia. 2022 Aug;65(8):1251-1261. doi: 10.1007/s00125-022-05715-4. Epub 2022 May 17.
8
Evaluating the Efficacy and Safety of Tirzepatide on Glycaemic and Non-glycaemic Outcomes in Diabetes: A Systematic Review of Meta-Analyses.评估替尔泊肽对糖尿病患者血糖及非血糖结局的疗效和安全性：一项Meta分析的系统评价
Cureus. 2024 Mar 26;16(3):e56939. doi: 10.7759/cureus.56939. eCollection 2024 Mar.
9
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis.替尔泊肽治疗2型糖尿病患者的疗效和安全性：一项贝叶斯网络荟萃分析。
Front Pharmacol. 2022 Oct 14;13:998816. doi: 10.3389/fphar.2022.998816. eCollection 2022.
10
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials.在没有糖尿病的超重或肥胖成年人中，替西帕肽与安慰剂的疗效和安全性：系统评价和随机对照试验的荟萃分析。
Int J Clin Pharm. 2024 Dec;46(6):1268-1280. doi: 10.1007/s11096-024-01779-x. Epub 2024 Jul 22.

引用本文的文献

1
Assessing the Safety of Semaglutide and Tirzepatide in Black and Asian Populations: A Narrative Review.评估司美格鲁肽和替尔泊肽在黑人和亚洲人群中的安全性：一项叙述性综述。
Cureus. 2025 Jul 2;17(7):e87188. doi: 10.7759/cureus.87188. eCollection 2025 Jul.